David Sheppard

Title: David Sheppard: Innovator in Pharmaceutical Compounds

Introduction

David Sheppard is a notable inventor based in NR Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific conditions. With a total of 2 patents to his name, Sheppard's work is focused on improving health outcomes through innovative treatments.

Latest Patents

David Sheppard's latest patents include advancements in bisaryl-sulfonamides. These compounds and compositions are designed to treat or prevent conditions mediated by PPARγ or PPARδ. Specifically, the compounds modulate the function of these receptors, making them particularly useful in addressing diabetes, obesity, hypercholesterolemia, rheumatoid arthritis, and atherosclerosis. The detailed formulations of bisaryl-sulfonamide compounds highlight their potential in therapeutic applications.

Career Highlights

Sheppard is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions that address critical health issues. His contributions have been instrumental in advancing the understanding and treatment of various metabolic disorders.

Collaborations

David Sheppard has collaborated with notable colleagues, including Philippe Bergeron and Christopher Neil Farthing. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

David Sheppard's innovative work in the field of pharmaceuticals exemplifies the impact of targeted treatments on health. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.